Phosphorylation of p65(ReLA) on ser 547 by ATM represses NF-κb-dependent transcription of specific genes after genotoxic stress

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Sabatel, Hélène ^a   Di Valentin, Emmanuel ^a   Gloire, Geoffrey ^a,b   Dequiedt, Franck ^a   Piette, Jacques ^a   Habraken, Yvette ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Interface Entreprises Université Liège Science Park   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; HISTONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LYSINE; SERINE; SYNAPTOTAGMIN I; ANTINEOPLASTIC AGENT; ATM PROTEIN; ATM PROTEIN, HUMAN; ETOPOSIDE; RELA PROTEIN, HUMAN; TRANSCRIPTION FACTOR RELA;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DNA STRAND BREAKAGE; GENE EXPRESSION; GENE INDUCTION; GENOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTOMICS; WILD TYPE; AMINO ACID SUBSTITUTION; DNA DAMAGE; DNA RESPONSIVE ELEMENT; DRUG EFFECTS; GENETIC TRANSCRIPTION; GENETICS; HEK293 CELL LINE; METABOLISM; MISSENSE MUTATION; PHOSPHORYLATION;

AMINO ACID SUBSTITUTION; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ATAXIA TELANGIECTASIA MUTATED PROTEINS; DNA DAMAGE; ETOPOSIDE; HEK293 CELLS; HUMANS; MUTATION, MISSENSE; PHOSPHORYLATION; RESPONSE ELEMENTS; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC;

EID: 84862003013     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038246     Document Type: Article

References (49)

1. Harper JW, Elledge SJ, (2007) The DNA damage response: ten years after. Mol Cell 28: 739 745.
2. Jackson SP, Bartek J, (2009) The DNA-damage response in human biology and disease. Nature 461: 1071 1078.
3. Shiloh Y, (2006) The ATM-mediated DNA-damage response: taking shape. Trends Biochem Sci 31: 402 410.
4. Habraken Y, Piette J, (2006) NF-kappaB activation by double-strand breaks. Biochem Pharmacol 72: 1132 1141.
5. Sabatel H, Pirlot C, Piette J, Habraken Y, (2011) Importance of PIKKs in NF-kappaB activation by genotoxic stress. Biochem Pharmacol 82: 1371 1383.
6. Hayden MS, Ghosh S, (2008) Shared Principles in NF-[kappa]B Signaling. Cell 132: 344 362.
7. Perkins ND, (2007) Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8: 49 62.
8. Baud V, Karin M, (2009) Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov 8: 33 40.
9. Courtois G, Gilmore TD, (2006) Mutations in the NF-kappaB signaling pathway: implications for human disease. Oncogene 25: 6831 6843.
10. Hayden MS, Ghosh S, (2004) Signaling to NF-kappaB. Genes Dev 18: 2195 2224.
11. Oeckinghaus A, Ghosh S, (2009) The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol 1: a000034.
12. Wu ZH, Shi Y, Tibbetts RS, Miyamoto S, (2006) Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli. Science 311: 1141 1146.
13. Huang TT, Wuerzberger-Davis SM, Wu ZH, Miyamoto S, (2003) Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 115: 565 576.
14. Hinz M, Stilmann M, Arslan SC, Khanna KK, Dittmar G, (2010) A cytoplasmic ATM-TRAF6-cIAP1 module links nuclear DNA damage signaling to ubiquitin-mediated NF-kappaB activation. Mol Cell 40: 63 74.
15. Wu ZH, Wong ET, Shi Y, Niu J, Chen Z, (2010) ATM- and NEMO-dependent ELKS ubiquitination coordinates TAK1-mediated IKK activation in response to genotoxic stress. Mol Cell 40: 75 86.
16. Huang B, Yang XD, Lamb A, Chen LF, (2010) Posttranslational modifications of NF-kappaB: another layer of regulation for NF-kappaB signaling pathway. Cell Signal 22: 1282 1290.
17. Perkins ND, (2006) Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene 25: 6717 6730.
18. Fernandes N, Sun Y, Chen S, Paul P, Shaw RJ, (2005) DNA damage-induced association of ATM with its target proteins requires a protein interaction domain in the N terminus of ATM. J Biol Chem 280: 15158 15164.
19. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER, 3rd, Hurov KE, et al (2007) ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316: 1160 1166.
20. Kim ST, Lim DS, Canman CE, Kastan MB, (1999) Substrate specificities and identification of putative substrates of ATM kinase family members. J Biol Chem 274: 37538 37543.
21. Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, (1998) Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281: 1677 1679.
22. O'Shea JM, Perkins ND, (2008) Regulation of the RelA (p65) transactivation domain. Biochem Soc Trans 36: 603 608.
23. Rocha S, Campbell KJ, Perkins ND, (2003) p53- and Mdm2-independent repression of NF-kappa B transactivation by the ARF tumor suppressor. Mol Cell 12: 15 25.
24. O'Shea JM, Perkins ND, (2010) Thr435 phosphorylation regulates RelA (p65) NF-kappaB subunit transactivation. Biochem J 426: 345 354.
25. Piret B, Schoonbroodt S, Piette J, (1999) The ATM protein is required for sustained activation of NF-kappaB following DNA damage. Oncogene 18: 2261 2271.
26. Li N, Banin S, Ouyang H, Li GC, Courtois G, (2001) ATM is required for IkappaB kinase (IKKk) activation in response to DNA double strand breaks. J Biol Chem 276: 8898 8903.
27. Owen HR, Quadroni M, Bienvenut W, Buerki C, Hottiger MO, (2005) Identification of novel and cell type enriched cofactors of the transcription activation domain of RelA (p65 NF-kappaB). J Proteome Res 4: 1381 1390.
28. Miyamoto S, (2011) Nuclear initiated NF-kappaB signaling: NEMO and ATM take center stage. Cell Res 21: 116 130.
29. Campbell KJ, O'Shea JM, Perkins ND, (2006) Differential regulation of NF-kappaB activation and function by topoisomerase II inhibitors. BMC Cancer 6: 101.
30. Dunn GP, Old LJ, Schreiber RD, (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21: 137 148.
31. Karin M, (2009) NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol 1: a000141.
32. Bohuslav J, Chen LF, Kwon H, Mu Y, Greene WC, (2004) p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. J Biol Chem 279: 26115 26125.
33. Lawrence T, Bebien M, Liu GY, Nizet V, Karin M, (2005) IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation. Nature 434: 1138 1143.
34. Zhong H, Voll RE, Ghosh S, (1998) Phosphorylation of NF-[kappa]B p65 by PKA Stimulates Transcriptional Activity by Promoting a Novel Bivalent Interaction with the Coactivator CBP/p300. Molecular Cell 1: 661 671.
35. Wuerzberger-Davis SM, Nakamura Y, Seufzer BJ, Miyamoto S, (2007) NF-kappaB activation by combinations of NEMO SUMOylation and ATM activation stresses in the absence of DNA damage. Oncogene 26: 641 651.
36. Guo Z, Kozlov S, Lavin MF, Person MD, Paull TT, (2010) ATM activation by oxidative stress. Science 330: 517 521.
37. Choudhary S, Rosenblatt KP, Fang L, Tian B, Wu ZH, (2011) High Throughput Short Interfering RNA (siRNA) Screening of the Human Kinome Identifies Novel Kinases Controlling the Canonical Nuclear Factor-{kappa}B (NF-{kappa}B) Activation Pathway. J Biol Chem 286: 37187 37195.
38. Horion J, Gloire G, El Mjiyad N, Quivy V, Vermeulen L, (2007) Histone deacetylase inhibitor trichostatin A sustains sodium pervanadate-induced NF-kappaB activation by delaying IkappaBalpha mRNA resynthesis: comparison with tumor necrosis factor alpha. J Biol Chem 282: 15383 15393.
39. Place RF, Noonan EJ, Giardina C, (2005) HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha. Biochem Pharmacol 70: 394 406.
40. Hu J, Colburn NH, (2005) Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding. Mol Cancer Res 3: 100 109.
41. Hoberg JE, Popko AE, Ramsey CS, Mayo MW, (2006) IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300. Mol Cell Biol 26: 457 471.
42. Barre B, Coqueret O, Perkins ND, (2010) Regulation of activity and function of the p52 NF-kappaB subunit following DNA damage. Cell Cycle 9: 4795 4804.
43. Schneider G, Henrich A, Greiner G, Wolf V, Lovas A, (2010) Cross talk between stimulated NF-kappaB and the tumor suppressor p53. Oncogene 29: 2795 2806.
44. Frank AK, Leu JI, Zhou Y, Devarajan K, Nedelko T, (2011) The codon 72 polymorphism of p53 regulates interaction with NF-{kappa}B and transactivation of genes involved in immunity and inflammation. Mol Cell Biol 31: 1201 1213.
45. Khanna KK, Keating KE, Kozlov S, Scott S, Gatei M, (1998) ATM associates with and phosphorylates p53: mapping the region of interaction. Nat Genet 20: 398 400.
46. Emi N, Friedmann T, Yee JK, (1991) Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus. J Virol 65: 1202 1207.
47. Dejardin E, Bonizzi G, Bellahcene A, Castronovo V, Merville MP, (1995) Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells. Oncogene 11: 1835 1841.
48. Schoonbroodt S, Ferreira V, Best-Belpomme M, Boelaert JR, Legrand-Poels S, (2000) Crucial role of the amino-terminal tyrosine residue 42 and the carboxyl-terminal PEST domain of I kappa B alpha in NF-kappa B activation by an oxidative stress. J Immunol 164: 4292 4300.
49. Takaesu G, Surabhi RM, Park KJ, Ninomiya-Tsuji J, Matsumoto K, (2003) TAK1 is critical for IkappaB kinase-mediated activation of the NF-kappaB pathway. J Mol Biol 326: 105 115.